Vrouwe, J. P. M., Kamerling, I. M. C., vanEsdonk, M. J., Metselaar, J. M., Stuurman, F. E., derPluijm, G. v., . . . Osanto, S. (2021). An exploratory first‐in‐man study to investigate the pharmacokinetics and safety of liposomal dexamethasone at a 2‐ and 1‐week interval in patients with metastatic castration resistant prostate cancer. Wiley.
Chicago Style (17th ed.) CitationVrouwe, Josephina P. M., Ingrid M. C. Kamerling, Michiel J. vanEsdonk, Josbert M. Metselaar, Frederik E. Stuurman, Gabri van derPluijm, Jacobus Burggraaf, and Susanne Osanto. An Exploratory First‐in‐man Study to Investigate the Pharmacokinetics and Safety of Liposomal Dexamethasone at a 2‐ and 1‐week Interval in Patients with Metastatic Castration Resistant Prostate Cancer. Wiley, 2021.
MLA (8th ed.) CitationVrouwe, Josephina P. M., et al. An Exploratory First‐in‐man Study to Investigate the Pharmacokinetics and Safety of Liposomal Dexamethasone at a 2‐ and 1‐week Interval in Patients with Metastatic Castration Resistant Prostate Cancer. Wiley, 2021.